By G HossainPosted on August 25, 2025Posted in Pharmaceutical & Bio Science, UncategorizedTagged bio science career, blogs, business career news, career tips, job blog, job news, RJF Pharmaceutical Jobs The deal extends AbbVie’s commitment to the psychedelics space and depression, after emraclidine’s high-profile flop in schizophrenia last November. Unswayed by Cerevel Failure, AbbVie Buys Gilgamesh’s Depression Drug for $1.2B Post navigation Arnatar Debuts With $52M To Advance RNA Therapies That Go Beyond SilencingBiotech Finally Has an IPO After Months-Long Freeze